AB 1895 (Weber, D-La Mesa)
Follow
Pending a hearing in the Assembly Health Committee
AB 1895 would require general acute care hospitals whose labor and delivery (L&D) units are at risk of closure within 12 months to report specified information to the California Department of Public Health, Department of Health Care Access and Information, and the chairs of the Senate and Assembly Health committees. The required information includes the number of medical staff and employees working in the maternity ward and the number of deliveries per month over the previous 12 months. The bill would also require hospitals that have L&D units at risk of closure to provide public notice of the potential closure and to post that notice on their websites 90 days in advance of the proposed closure. CHA continues to work with Dr. Weber’s office to address hospitals’ concerns.
AB 2300 (Wilson, D-Suisun City)
Follow
April 2 hearing in the Assembly Health Committee. To be heard in the Assembly Environmental Safety and Toxic Materials Committee.
AB 2300 would phase out the manufacture, sale, or distribution of IV bags and IV tubing made with intentionally added Di (2-ethylhexyl) phthalate (DEHP). Beginning Jan. 1, 2026, the manufacture, sale, or distribution of IV bags with intentionally added DEPH would be prohibited. Beginning Jan. 1, 2031, this prohibition would be extended to IV tubing intended for use in neonatal intensive care units, nutrition infusions, or oncology treatment infusions.
SB 1300 (Cortese, D-Campbell)
Oppose
April 3 hearing in the Senate Health Committee
SB 1300 would extend the notice period for proposed closures or eliminations of inpatient psychiatric or maternity services from 90 days to 120 days. It would also require the facilities to provide an impact analysis report (paid for by the hospital) to the Department of Health Care Access and Information for review and certification before providing notice of the proposed closure or elimination. If the loss of beds would impact the community’s health, the bill would also require the California Department of Public Health to prioritize and expedite the licensing of additional beds as necessary to mitigate the negative impacts identified in the report.